| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abatacept for the prevention of GVHD in patients receiving mismatched unrelated transplants: a real-world analysis
|
Raghunandan, Sharmila
|
|
|
|
16 |
p. 4395-4399
|
artikel
|
| 2 |
Abatacept is effective as GVHD prophylaxis in unrelated donor stem cell transplantation for children with severe sickle cell disease
|
Ngwube, Alexander
|
|
|
|
16 |
p. 3894-3899
|
artikel
|
| 3 |
Abraham AA, John TD, Keller MD, et al. Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients. Blood Adv. 2019;3(14):2057-2068.
|
|
|
|
|
16 |
p. 2453
|
artikel
|
| 4 |
A case of lenalidomide-dependent myelodysplastic syndrome
|
Miller, Ira J.
|
|
|
|
16 |
p. 1238-1242
|
artikel
|
| 5 |
Activation of MYC, a bona fide client of HSP90, contributes to intrinsic ibrutinib resistance in mantle cell lymphoma
|
Lee, Jimmy
|
|
|
|
16 |
p. 2039-2051
|
artikel
|
| 6 |
Activity of mRNA COVID-19 vaccines in patients with lymphoid malignancies
|
Crombie, Jennifer L.
|
|
|
|
16 |
p. 3062-3065
|
artikel
|
| 7 |
Adding venetoclax to lenalidomide and rituximab is safe and effective in patients with untreated mantle cell lymphoma
|
Phillips, Tycel J.
|
|
|
|
16 |
p. 4518-4527
|
artikel
|
| 8 |
Allelic variation of KIR and HLA tunes the cytolytic payload and determines functional hierarchy of NK cell repertoires
|
Philippon, Camille
|
|
|
|
16 |
p. 4492-4504
|
artikel
|
| 9 |
Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents
|
Roeker, Lindsey E.
|
|
|
|
16 |
p. 3977-3989
|
artikel
|
| 10 |
Alternative donor hematopoietic stem cell transplantation for sickle cell disease
|
Gilman, Andrew L.
|
|
|
|
16 |
p. 1215-1223
|
artikel
|
| 11 |
Antiangiogenic effects of decorin restored by unfractionated, low molecular weight, and nonanticoagulant heparins
|
Chui, Amy K.L.
|
|
|
|
16 |
p. 1243-1253
|
artikel
|
| 12 |
Antiviral prophylaxis for cytomegalovirus infection in allogeneic hematopoietic cell transplantation
|
Chen, Kaiwen
|
|
|
|
16 |
p. 2159-2175
|
artikel
|
| 13 |
A phase 3 randomized study (HOMER) of ofatumumab vs rituximab in iNHL relapsed after rituximab-containing therapy
|
Maloney, David G.
|
|
|
|
16 |
p. 3886-3893
|
artikel
|
| 14 |
Approval of tagraxofusp-erzs for blastic plasmacytoid dendritic cell neoplasm
|
Pemmaraju, Naveen
|
|
|
|
16 |
p. 4020-4027
|
artikel
|
| 15 |
A predictive algorithm using clinical and laboratory parameters may assist in ruling out and in diagnosing MDS
|
Oster, Howard S.
|
|
|
|
16 |
p. 3066-3075
|
artikel
|
| 16 |
A randomized comparison of CPX-351 and FLAG-Ida in adverse karyotype AML and high-risk MDS: the UK NCRI AML19 trial
|
Othman, Jad
|
|
|
|
16 |
p. 4539-4549
|
artikel
|
| 17 |
Arhgef2 regulates mitotic spindle orientation in hematopoietic stem cells and is essential for productive hematopoiesis
|
Chan, Derek C.H.
|
|
|
|
16 |
p. 3120-3133
|
artikel
|
| 18 |
A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile
|
Salmeron-Villalobos, Julia
|
|
|
|
16 |
p. 4661-4674
|
artikel
|
| 19 |
“Autoimmune HIT” antibodies in diagnostic samples are a potential artifact and not associated with more severe outcomes
|
Kanack, Adam J.
|
|
|
|
16 |
p. 4431-4434
|
artikel
|
| 20 |
B-cell acute lymphoblastic leukemia in patients with germline RUNX1 mutations
|
Six, Kathryn A.
|
|
|
|
16 |
p. 3199-3202
|
artikel
|
| 21 |
Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1
|
Obiorah, Ifeyinwa Emmanuela
|
|
|
|
16 |
p. 3203-3215
|
artikel
|
| 22 |
Biological and structural characterization of murine TRALI antibody reveals increased Fc-mediated complement activation
|
Zeeuw van der Laan, Eveline A.N.
|
|
|
|
16 |
p. 3875-3885
|
artikel
|
| 23 |
Building access to care in adult sickle cell disease: defining models of care, essential components, and economic aspects
|
Kanter, Julie
|
|
|
|
16 |
p. 3804-3813
|
artikel
|
| 24 |
Cardiac events after standard of care idecabtagene vicleucel for relapsed and refractory multiple myeloma
|
Lee, Dae Hyun
|
|
|
|
16 |
p. 4247-4257
|
artikel
|
| 25 |
CD19 antibody-drug conjugate therapy in DLBCL does not preclude subsequent responses to CD19-directed CAR T-cell therapy
|
Thapa, Bicky
|
|
|
|
16 |
p. 3850-3852
|
artikel
|
| 26 |
CD38 as a pan-hematologic target for chimeric antigen receptor T cells
|
Glisovic-Aplenc, Tina
|
|
|
|
16 |
p. 4418-4430
|
artikel
|
| 27 |
CD34 + -selected stem cell boost can safely improve cytopenias following CAR T-cell therapy
|
Mullanfiroze, Khushnuma
|
|
|
|
16 |
p. 4715-4718
|
artikel
|
| 28 |
Cell-free DNA measurable residual disease as a predictor of postallogeneic hematopoietic cell transplant outcomes
|
Pasca, Sergiu
|
|
|
|
16 |
p. 4660-4670
|
artikel
|
| 29 |
Cellular and molecular profiling of T-cell subsets at the onset of human acute GVHD
|
Latis, Eleonora
|
|
|
|
16 |
p. 3927-3942
|
artikel
|
| 30 |
Cellular distribution of mutations and association with disease risk in Langerhans cell histiocytosis without BRAF V600E
|
Milne, Paul
|
|
|
|
16 |
p. 4901-4904
|
artikel
|
| 31 |
Characterization of the human platelet N- and O-glycome upon storage using tandem mass spectrometry
|
Rosenbalm, Katelyn E.
|
|
|
|
16 |
p. 4278-4290
|
artikel
|
| 32 |
Circulating tumor DNA adds specificity to PET after axicabtagene ciloleucel in large B-cell lymphoma
|
Dean, Erin A.
|
|
|
|
16 |
p. 4608-4618
|
artikel
|
| 33 |
Clinical and radiologic correlates of neurotoxicity after axicabtagene ciloleucel in large B-cell lymphoma
|
Strati, Paolo
|
|
|
|
16 |
p. 3943-3951
|
artikel
|
| 34 |
Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials
|
Wojdacz, Tomasz K.
|
|
|
|
16 |
p. 2474-2481
|
artikel
|
| 35 |
Clinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specified
|
Bourbon, Estelle
|
|
|
|
16 |
p. 3227-3239
|
artikel
|
| 36 |
CNL and aCML are prognostically distinct: a large National Cancer Database analysis
|
Tremblay, Douglas
|
|
|
|
16 |
p. 4400-4402
|
artikel
|
| 37 |
Comorbid and inflammatory characteristics of genetic subtypes of clonal hematopoiesis
|
Cook, Elina K.
|
|
|
|
16 |
p. 2482-2486
|
artikel
|
| 38 |
Comparative efficacy and tolerability of novel agents vs chemotherapy in relapsed and refractory T-cell lymphomas: a meta-analysis
|
Shafagati, Nazila
|
|
|
|
16 |
p. 4740-4762
|
artikel
|
| 39 |
Comparison of reversal activity and mechanism of action of UHRA, andexanet, and PER977 on heparin and oral FXa inhibitors
|
Kalathottukaren, Manu T.
|
|
|
|
16 |
p. 2104-2114
|
artikel
|
| 40 |
Complement-mediated thrombotic microangiopathy associated with lupus nephritis
|
Park, Mi Hee
|
|
|
|
16 |
p. 2090-2094
|
artikel
|
| 41 |
Computational modeling and confirmation of leukemia-associated minor histocompatibility antigens
|
Lansford, Jefferson L.
|
|
|
|
16 |
p. 2052-2062
|
artikel
|
| 42 |
Computer vision quantitation of erythrocyte shape abnormalities provides diagnostic, prognostic, and mechanistic insight
|
Foy, Brody H.
|
|
|
|
16 |
p. 4621-4630
|
artikel
|
| 43 |
Concordance of peripheral blood and bone marrow measurable residual disease in adult acute lymphoblastic leukemia
|
Muffly, Lori
|
|
|
|
16 |
p. 3147-3151
|
artikel
|
| 44 |
Conditioning intensity in secondary AML with prior myelodysplastic syndrome/myeloproliferative disorders: an EBMT ALWP study
|
Sengsayadeth, Salyka
|
|
|
|
16 |
p. 2127-2135
|
artikel
|
| 45 |
Current clinical practices and challenges in molecular testing: a GOAL Consortium Hematopathology Working Group report
|
Lee, Thomas D.
|
|
|
|
16 |
p. 4599-4607
|
artikel
|
| 46 |
Cytokine pathway variants modulate platelet production: IFNA16 is a thrombocytosis susceptibility locus in humans
|
Gnatenko, Dmitri V.
|
|
|
|
16 |
p. 4884-4900
|
artikel
|
| 47 |
Delayed-onset cytomegalovirus infection is frequent after discontinuing letermovir in cord blood transplant recipients
|
Hill, Joshua A.
|
|
|
|
16 |
p. 3113-3119
|
artikel
|
| 48 |
Delivering HDAC over 3 or 5 days as consolidation in AML impacts health care resource consumption but not outcome
|
Dumas, Pierre-Yves
|
|
|
|
16 |
p. 3840-3849
|
artikel
|
| 49 |
Development and characterization of prototypes for in vitro and in vivo mouse models of ibrutinib-resistant CLL
|
Aslan, Burcu
|
|
|
|
16 |
p. 3134-3146
|
artikel
|
| 50 |
Diagnosing TMAs by automated red cell morphology analyses
|
Billett, Henny H.
|
|
|
|
16 |
p. 4631-4632
|
artikel
|
| 51 |
Diffuse large B-cell lymphomas have spatially defined, tumor immune microenvironments revealed by high-parameter imaging
|
Wright, Kyle T.
|
|
|
|
16 |
p. 4633-4646
|
artikel
|
| 52 |
Dinaciclib enhances natural killer cell cytotoxicity against acute myelogenous leukemia
|
Yun, Hyun Don
|
|
|
|
16 |
p. 2448-2452
|
artikel
|
| 53 |
Dominant epitopes presented by prevalent HLA alleles permit wide use of banked CMVpp65 T cells in adoptive therapy
|
Hasan, Aisha N.
|
|
|
|
16 |
p. 4859-4872
|
artikel
|
| 54 |
Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromes
|
Itzykson, Raphael
|
|
|
|
16 |
p. 2079-2089
|
artikel
|
| 55 |
Editorial Board
|
|
|
|
|
16 |
p. i
|
artikel
|
| 56 |
Editorial Board
|
|
|
|
|
16 |
p. i
|
artikel
|
| 57 |
Editorial Board
|
|
|
|
|
16 |
p. i
|
artikel
|
| 58 |
Editorial Board
|
|
|
|
|
16 |
p. i
|
artikel
|
| 59 |
Editorial Board
|
|
|
|
|
16 |
p. i
|
artikel
|
| 60 |
Editorial Board
|
|
|
|
|
16 |
p. i
|
artikel
|
| 61 |
Editorial Board
|
|
|
|
|
16 |
p. i
|
artikel
|
| 62 |
Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions
|
Major, Ajay
|
|
|
|
16 |
p. 4528-4538
|
artikel
|
| 63 |
Efficacy of folinic acid rescue following MTX GVHD prophylaxis: results of a double-blind, randomized, controlled study
|
Yeshurun, Moshe
|
|
|
|
16 |
p. 3822-3828
|
artikel
|
| 64 |
Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma
|
Perry, C.
|
|
|
|
16 |
p. 3053-3061
|
artikel
|
| 65 |
Efficacy, safety, and pharmacokinetics of a new, ready-to-use, liquid hydroxyurea in children with sickle cell anemia
|
Rankine-Mullings, Angela
|
|
|
|
16 |
p. 4319-4322
|
artikel
|
| 66 |
Emerging clinical trial designs may accelerate translation in hematology: lessons from COVID-19
|
Neal, Matthew D.
|
|
|
|
16 |
p. 4710-4714
|
artikel
|
| 67 |
Evaluation of induction chemotherapies after hypomethylating agent failure in myelodysplastic syndromes and acute myeloid leukemia
|
Ball, Brian
|
|
|
|
16 |
p. 2063-2071
|
artikel
|
| 68 |
Exposure-response analysis of alemtuzumab in pediatric allogeneic HSCT for nonmalignant diseases: the ARTIC study
|
Achini-Gutzwiller, Federica R.
|
|
|
|
16 |
p. 4462-4474
|
artikel
|
| 69 |
Felber M, Steward CG, Kentouche K, et al. Targeted busulfan-based reduced-intensity conditioning and HLA-matched HSCT cure hemophagocytic lymphohistiocytosis.Blood Adv.2020;4(9):1998-2010.
|
|
|
|
|
16 |
p. 3926
|
artikel
|
| 70 |
Final results of a phase 2 clinical trial of LCL161, an oral SMAC mimetic for patients with myelofibrosis
|
Pemmaraju, Naveen
|
|
|
|
16 |
p. 3163-3173
|
artikel
|
| 71 |
Five decades of low intensity and low survival: adapting intensified regimens to cure pediatric Burkitt lymphoma in Africa
|
Ozuah, Nmazuo W.
|
|
|
|
16 |
p. 4007-4019
|
artikel
|
| 72 |
Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology study
|
Bhatnagar, Bhavana
|
|
|
|
16 |
p. 4671-4675
|
artikel
|
| 73 |
Front Matter
|
|
|
|
|
16 |
p. ii
|
artikel
|
| 74 |
Genomic landscape of TP53-mutated myeloid malignancies
|
Abel, Haley J.
|
|
|
|
16 |
p. 4586-4598
|
artikel
|
| 75 |
Greenwood M, Trahair T, Sutton R, et al. An MRD-stratified pediatric protocol is as deliverable in adolescents and young adults as in children with ALL. Blood Adv. 2021;5(24):5574-5583.
|
|
|
|
|
16 |
p. 4620
|
artikel
|
| 76 |
Guideline-based indicators for adult patients with myelodysplastic syndromes
|
Stojkov, Kristina
|
|
|
|
16 |
p. 4029-4044
|
artikel
|
| 77 |
Hematopoietic cell transplant for acute myeloid leukemia and myelodysplastic syndrome: conditioning regimen intensity
|
Eapen, Mary
|
|
|
|
16 |
p. 2095-2103
|
artikel
|
| 78 |
Higher graft cell dose does not influence development of acute or chronic GVHD in haploidentical transplantation using PTCy
|
Nawas, Mariam T.
|
|
|
|
16 |
p. 4475-4478
|
artikel
|
| 79 |
High-throughput sequencing reveals novel features of immunoglobulin gene rearrangements in Burkitt lymphoma
|
Lombardo, Katharine A.
|
|
|
|
16 |
p. 1261-1262
|
artikel
|
| 80 |
HMGA2 expression defines a subset of human AML with immature transcriptional signature and vulnerability to G2/M inhibition
|
Moison, Céline
|
|
|
|
16 |
p. 4793-4806
|
artikel
|
| 81 |
How I read an article that uses machine learning methods
|
Nazha, Aziz
|
|
|
|
16 |
p. 4550-4554
|
artikel
|
| 82 |
Human NK cells prime inflammatory DC precursors to induce Tc17 differentiation
|
Clavijo-Salomon, Maria A.
|
|
|
|
16 |
p. 3990-4006
|
artikel
|
| 83 |
ICH in primary or metastatic brain cancer patients with or without anticoagulant treatment: a systematic review and meta-analysis
|
Giustozzi, Michela
|
|
|
|
16 |
p. 4873-4883
|
artikel
|
| 84 |
ICOS immunoPET enables visualization of activated T cells and early diagnosis of murine acute gastrointestinal GvHD
|
Xiao, Zunyu
|
|
|
|
16 |
p. 4782-4792
|
artikel
|
| 85 |
Identification of USP9X as a leukemia susceptibility gene
|
Sisoudiya, Saumya Dushyant
|
|
|
|
16 |
p. 4563-4575
|
artikel
|
| 86 |
Identifying experts for clinical practice guidelines: perspectives from the ASH Guideline Oversight Subcommittee
|
Byrne, Michael
|
|
|
|
16 |
p. 4323-4326
|
artikel
|
| 87 |
Impact of donor age and kinship on clinical outcomes after T-cell–replete haploidentical transplantation with PT-Cy
|
Mariotti, Jacopo
|
|
|
|
16 |
p. 3900-3912
|
artikel
|
| 88 |
Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD
|
Akahoshi, Yu
|
|
|
|
16 |
p. 4479-4491
|
artikel
|
| 89 |
Individual phosphatidylinositol transfer proteins have distinct functions that do not involve lipid transfer activity
|
Zhao, Liang
|
|
|
|
16 |
p. 4233-4246
|
artikel
|
| 90 |
In-person and virtual assessment of short physical performance battery test in older adults with myeloid malignancies
|
Sanapala, Chandrika
|
|
|
|
16 |
p. 4414-4417
|
artikel
|
| 91 |
Ixazomib, dexamethasone, and rituximab in treatment-naive patients with Waldenström macroglobulinemia: long-term follow-up
|
Castillo, Jorge J.
|
|
|
|
16 |
p. 3952-3959
|
artikel
|
| 92 |
Lentiviral correction of enzymatic activity restrains macrophage inflammation in adenosine deaminase 2 deficiency
|
Zoccolillo, Matteo
|
|
|
|
16 |
p. 3174-3187
|
artikel
|
| 93 |
Loncastuximab tesirine in relapsed/refractory high-grade B-cell lymphoma: a subgroup analysis from the LOTIS-2 study
|
Alderuccio, Juan P.
|
|
|
|
16 |
p. 4736-4739
|
artikel
|
| 94 |
Longitudinal metabolic study of red blood cells from patients undergoing gender-affirming testosterone therapy
|
Roy, Micaela Kalani
|
|
|
|
16 |
p. 4269-4277
|
artikel
|
| 95 |
Long-term disease control of Langerhans cell histiocytosis using combined BRAF and MEK inhibition
|
Awada, Gil
|
|
|
|
16 |
p. 2156-2158
|
artikel
|
| 96 |
Long-term effect of hematopoietic cell transplantation on systemic inflammation in patients with mucopolysaccharidoses
|
van den Broek, Brigitte T.A.
|
|
|
|
16 |
p. 3092-3101
|
artikel
|
| 97 |
Long-term outcome of patients with relapsed/refractory B-cell non-Hodgkin lymphoma treated with blinatumomab
|
Dufner, Vera
|
|
|
|
16 |
p. 2491-2498
|
artikel
|
| 98 |
Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma
|
Jaeger, Ulrich
|
|
|
|
16 |
p. 4816-4820
|
artikel
|
| 99 |
Loss of erythroblasts in acute myeloid leukemia causes iron redistribution with clinical implications
|
Lopes, Marta
|
|
|
|
16 |
p. 3102-3112
|
artikel
|
| 100 |
Loss-of-function lesions impact B-cell development and fitness but are insufficient to drive CLL in mouse models
|
Hacken, Elisa ten
|
|
|
|
16 |
p. 4514-4517
|
artikel
|
| 101 |
Low incidence of invasive fungal disease following CD19 chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma
|
Little, Jessica S.
|
|
|
|
16 |
p. 4821-4830
|
artikel
|
| 102 |
Mazzara S, Travaini L, Botta F, et al. Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL. Blood Adv. 2023;7(4):630-643.
|
|
|
|
|
16 |
p. 4619
|
artikel
|
| 103 |
Medical marijuana certification for patients with sickle cell disease: a report of a single center experience
|
Curtis, Susanna A.
|
|
|
|
16 |
p. 3814-3821
|
artikel
|
| 104 |
Monocyte procoagulant responses to anthrax peptidoglycan are reinforced by proinflammatory cytokine signaling
|
Popescu, Narcis Ioan
|
|
|
|
16 |
p. 2436-2447
|
artikel
|
| 105 |
More evidence for low-dose IL-2 for chronic GVHD in children
|
Levine, John E.
|
|
|
|
16 |
p. 4658-4659
|
artikel
|
| 106 |
Moving toward a conceptualization of measurable residual disease in myelodysplastic syndromes
|
Schulz, Eduard
|
|
|
|
16 |
p. 4381-4394
|
artikel
|
| 107 |
Multiple functional variants in the IL1RL1 region are pretransplant markers for risk of GVHD and infection deaths
|
Karaesmen, Ezgi
|
|
|
|
16 |
p. 2512-2524
|
artikel
|
| 108 |
Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults
|
Symons, Heather J.
|
|
|
|
16 |
p. 3913-3925
|
artikel
|
| 109 |
Neutrophils from hereditary hemochromatosis patients are protected from iron excess and are primed
|
Renassia, Cyril
|
|
|
|
16 |
p. 3853-3863
|
artikel
|
| 110 |
Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohort
|
Spinner, Michael A.
|
|
|
|
16 |
p. 2454-2464
|
artikel
|
| 111 |
Normal peripheral blood neutrophil numbers accompanying ELANE whole gene deletion mutation
|
Horwitz, Marshall S.
|
|
|
|
16 |
p. 2470-2473
|
artikel
|
| 112 |
Nurselike cells sequester B cells in disorganized lymph nodes in chronic lymphocytic leukemia via alternative production of CCL21
|
Zaaboub, Rim
|
|
|
|
16 |
p. 4691-4704
|
artikel
|
| 113 |
Olutasidenib: from bench to bedside
|
Venugopal, Sangeetha
|
|
|
|
16 |
p. 4358-4365
|
artikel
|
| 114 |
Ontogenesis of functional platelet subpopulations from preterm and term neonates to adulthood: The PLINIUS study
|
Weiss, Lukas J.
|
|
|
|
16 |
p. 4334-4348
|
artikel
|
| 115 |
Optimized vitamin D repletion with oral thin film cholecalciferol in patients undergoing stem cell transplant
|
Bartlett, Allison L.
|
|
|
|
16 |
p. 4555-4562
|
artikel
|
| 116 |
Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm study
|
Deng, Li-Juan
|
|
|
|
16 |
p. 4349-4357
|
artikel
|
| 117 |
Osteonecrosis of the femoral head in sickle cell disease: prevalence, comorbidities, and surgical outcomes in California
|
Adesina, Oyebimpe
|
|
|
|
16 |
p. 1287-1295
|
artikel
|
| 118 |
Outcomes of patients with primary refractory multiple myeloma in the era of triplet and quadruplet induction therapy
|
Charalampous, Charalampos
|
|
|
|
16 |
p. 4371-4380
|
artikel
|
| 119 |
Patient-derived xenografts of low-grade B-cell lymphomas demonstrate roles of the tumor microenvironment
|
Burack, W. Richard
|
|
|
|
16 |
p. 1263-1273
|
artikel
|
| 120 |
Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial
|
Bassan, Renato
|
|
|
|
16 |
p. 4448-4461
|
artikel
|
| 121 |
Platelets mediate serological memory to neutralize viruses in vitro and in vivo
|
Schrottmaier, Waltraud C.
|
|
|
|
16 |
p. 3971-3976
|
artikel
|
| 122 |
Predictive modeling of complex ABO glycan phenotypes by lectin microarrays
|
Anani, Waseem Q.
|
|
|
|
16 |
p. 3960-3970
|
artikel
|
| 123 |
Prognostic impact of the ELN2017 risk classification in patients with AML receiving allogeneic transplantation
|
Grimm, Juliane
|
|
|
|
16 |
p. 3864-3874
|
artikel
|
| 124 |
Prospective external validation of biomarkers to predict acute graft-versus-host disease severity
|
Robin, Marie
|
|
|
|
16 |
p. 4763-4772
|
artikel
|
| 125 |
Real-world comparative effectiveness of acalabrutinib and ibrutinib in patients with chronic lymphocytic leukemia
|
Roeker, Lindsey E.
|
|
|
|
16 |
p. 4291-4301
|
artikel
|
| 126 |
Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host disease
|
Wobma, Holly
|
|
|
|
16 |
p. 4647-4657
|
artikel
|
| 127 |
Recombinant human thrombopoietin promotes platelet engraftment after umbilical cord blood transplantation
|
Tang, Baolin
|
|
|
|
16 |
p. 3829-3839
|
artikel
|
| 128 |
Reduced-dose WBRT as consolidation treatment for patients with primary CNS lymphoma: an LOC network study
|
Lesueur, Paul
|
|
|
|
16 |
p. 4807-4815
|
artikel
|
| 129 |
Return emergency department visits for recurrent pulmonary embolism symptoms in children and adolescents
|
Egan-Sherry, Dana
|
|
|
|
16 |
p. 4327-4333
|
artikel
|
| 130 |
Revision of RUNX1 variant curation rules
|
Feurstein, Simone
|
|
|
|
16 |
p. 4726-4730
|
artikel
|
| 131 |
RGS10 shapes the hemostatic response to injury through its differential effects on intracellular signaling by platelet agonists
|
Ma, Peisong
|
|
|
|
16 |
p. 2145-2155
|
artikel
|
| 132 |
Rural-urban disparities in place of death in hematologic malignancies in the United States, 2003 to 2019
|
Hussaini, S. M. Qasim
|
|
|
|
16 |
p. 4731-4734
|
artikel
|
| 133 |
Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy
|
Rejeski, Kai
|
|
|
|
16 |
p. 4719-4725
|
artikel
|
| 134 |
SAR443809: a selective inhibitor of the complement alternative pathway, targeting complement factor Bb
|
Rajagopal, Vaishnavi
|
|
|
|
16 |
p. 4258-4268
|
artikel
|
| 135 |
Serial treatment of relapsed/refractory multiple myeloma with different BCMA-targeting therapies
|
Cohen, Adam D.
|
|
|
|
16 |
p. 2487-2490
|
artikel
|
| 136 |
Sexual violence as a precipitator of chronic pain in young adults with sickle cell disease
|
Chopra, Maya
|
|
|
|
16 |
p. 4831-4833
|
artikel
|
| 137 |
Siltuximab is associated with improved progression-free survival in idiopathic multicentric Castleman disease
|
van Rhee, Frits
|
|
|
|
16 |
p. 4773-4781
|
artikel
|
| 138 |
Single-cell heterogeneity in Sézary syndrome
|
Buus, Terkild Brink
|
|
|
|
16 |
p. 2115-2126
|
artikel
|
| 139 |
Single-cell spatial analysis of tumor immune architecture in diffuse large B-cell lymphoma
|
Colombo, Anthony R.
|
|
|
|
16 |
p. 4675-4690
|
artikel
|
| 140 |
Structure and diversification of immunoglobulin genes in African Burkitt lymphoma
|
Küppers, Ralf
|
|
|
|
16 |
p. 1259-1260
|
artikel
|
| 141 |
Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention
|
Hamilton, Betty K.
|
|
|
|
16 |
p. 4505-4513
|
artikel
|
| 142 |
Telomerase-targeted therapies in myeloid malignancies
|
Waksal, Julian A.
|
|
|
|
16 |
p. 4302-4314
|
artikel
|
| 143 |
Tetraspanins set the stage for bone marrow microenvironment–induced chemoprotection in hematologic malignancies
|
Quagliano, Anthony
|
|
|
|
16 |
p. 4403-4413
|
artikel
|
| 144 |
The association of CMV with NK-cell reconstitution depends on graft source: results from BMT CTN-0201 samples
|
Rashidi, Armin
|
|
|
|
16 |
p. 2465-2469
|
artikel
|
| 145 |
The extent of residual WT HSPCs is associated with the degree of anemia in patients with SF3B1-mutated MDS-RS
|
Hofman, Isabel Juliana F.
|
|
|
|
16 |
p. 4705-4709
|
artikel
|
| 146 |
The frequency of joint hemorrhages and procedures in nonsevere hemophilia A vs B
|
Soucie, J. Michael
|
|
|
|
16 |
p. 2136-2144
|
artikel
|
| 147 |
The GPCR adaptor protein norbin suppresses the neutrophil-mediated immunity of mice to pneumococcal infection
|
Pantarelli, Chiara
|
|
|
|
16 |
p. 3076-3091
|
artikel
|
| 148 |
The management of venous thromboembolism in hospitalized patients with COVID-19
|
Spyropoulos, Alex C.
|
|
|
|
16 |
p. 4028
|
artikel
|
| 149 |
The odyssey of pacritinib in myelofibrosis
|
Venugopal, Sangeetha
|
|
|
|
16 |
p. 4905-4913
|
artikel
|
| 150 |
The predictive value of PNH clones, 6p CN-LOH, and clonal TCR gene rearrangement for aplastic anemia diagnosis
|
Shah, Yash B.
|
|
|
|
16 |
p. 3216-3226
|
artikel
|
| 151 |
The ROR1 antibody-drug conjugate huXBR1-402-G5-PNU effectively targets ROR1+ leukemia
|
Hu, Eileen Y.
|
|
|
|
16 |
p. 3152-3162
|
artikel
|
| 152 |
Time to progression of disease and outcomes with second-line BTK inhibitors in relapsed/refractory mantle cell lymphoma
|
Villa, Diego
|
|
|
|
16 |
p. 4576-4585
|
artikel
|
| 153 |
Traumatic vessel injuries initiating hemostasis generate high shear conditions
|
Yakusheva, Alexandra A.
|
|
|
|
16 |
p. 4834-4846
|
artikel
|
| 154 |
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study
|
Bachy, Emmanuel
|
|
|
|
16 |
p. 4435-4447
|
artikel
|
| 155 |
TREM-like transcript 1: a more sensitive marker of platelet activation than P-selectin in humans and mice
|
Smith, Christopher W.
|
|
|
|
16 |
p. 2072-2078
|
artikel
|
| 156 |
Use of letermovir in umbilical cord blood transplantation based on risk scores
|
Rivera Franco, Monica M.
|
|
|
|
16 |
p. 4315-4318
|
artikel
|
| 157 |
Use of the complement inhibitor Coversin to treat HSCT-associated TMA
|
Goodship, Timothy H.J.
|
|
|
|
16 |
p. 1254-1258
|
artikel
|
| 158 |
Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders
|
Stewart, James Peter
|
|
|
|
16 |
p. 3188-3198
|
artikel
|
| 159 |
Venetoclax-based therapies in pediatric advanced MDS and relapsed/refractory AML: a multicenter retrospective analysis
|
Masetti, Riccardo
|
|
|
|
16 |
p. 4366-4370
|
artikel
|
| 160 |
Venetoclax enhances the efficacy of therapeutic antibodies in B-cell malignancies by augmenting tumor cell phagocytosis
|
Vogiatzi, Fotini
|
|
|
|
16 |
p. 4847-4858
|
artikel
|
| 161 |
Vo P, Gooley, TA, Carpenter PA, et al. Prediction of outcomes after second-line treatment for acute graft-versus-host disease. Blood Adv. 2022;6(11):3220-3229.
|
|
|
|
|
16 |
p. 4735
|
artikel
|
| 162 |
Whole-exome sequencing in evaluation of patients with venous thromboembolism
|
Lee, Eun-Ju
|
|
|
|
16 |
p. 1224-1237
|
artikel
|
| 163 |
WNT ligands contribute to the immune response during septic shock and amplify endotoxemia-driven inflammation in mice
|
Gatica-Andrades, Marcela
|
|
|
|
16 |
p. 1274-1286
|
artikel
|
| 164 |
Zfp281 (ZBP-99) plays a functionally redundant role with Zfp148 (ZBP-89) during erythroid development
|
Woo, Andrew J.
|
|
|
|
16 |
p. 2499-2511
|
artikel
|
Tijdschrift beschrijving